For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…
DC Journal
Point: Medicaid Work Requirements Are a Common-Sense Reform
Medicaid is the government program that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Search Posts
Blog
The $60,000 Obama Health-Care Plan: It’s “Eye-Poppingly” Expensive on a Per-Person Basis
Obama’s health-care proposals will cost well over a trillion dollars, without providing universal coverage. They are so “eye-poppingly” expensive that even Congressional Democrats have…
Citation
Jimmy P’s Top Ten Blogs Posts of the Day
Blog
HHS Secretary: Health Insurance Industry Needs Competition… With Government
In an AP interview on Tuesday, Health and Human Services Secretary Kathleen Sebelius called for competition in the health insurance market. No, not between…
Op-Eds
FDA’s Bad Medicine
President Barack Obama promised to shake up the Food and Drug Administration, so it’s no surprise that his new FDA leadership team has made…
Blog
Obama’s Speech to AMA on Healthcare Misses the Point
In a speech before the American Medical Association on Monday, June 15, President Obama pitched his plan for heathcare reform. The main thrust of the…
Op-Eds
Will Americans (Literally) Be Dying For ObamaCare?
Remember Harry and Louise, the made-for-television couple whose advertisements helped scuttle the Clinton health care plan 16 years ago? President Barack Obama does. Every…
Blog
Senate Passes FDA Tobacco Regulation Bill; Obama Will Sign It
The Senate has just passed the FDA tobacco regulation bill by a 79-to-17 vote. The bill now goes to President Obama, who has…
Op-Eds
Senate Passes Bill to Give FDA Tobacco Regulation
The Senate has just passed the FDA tobacco regulation bill by a 79-to-17 vote. The bill now goes to President Obama, who has said…
Blog
FDA Poised to Regulate Tobacco, Which May Backfire
Congress is about to enact a bill to subject tobacco to FDA regulation. Mark Berlind notes one anomalous feature of the bill: it…
Blog
Regulation of the Day: Saving the Children
On June 26, the National Commission on Children and Disasters is having a meeting. They will be talking about another meeting from the day before.
Newsletter
Chrysler in the Supreme Court, Banning Plastic Bags and the Anniversary of “1984”
The Supreme Court blocks the bankruptcy reorganization of Chrysler. The director of the United Nations’ environmental program calls for a ban on plastic grocery bags.
Newsletter
Cap and Trade, GM’s Bankruptcy and BPA
Utilities worry about the costs associated with proposed “cap and trade” legislation for greenhouse gases. General Motors files for bankruptcy. Manufacturers fight off a proposed…
Newsletter
Chrysler’s Future, GMO Foods and the New Black Panter Party
A federal bankruptcy judge clears the way for Chrysler’s sale to Italian automaker Fiat. The government of Zimbabwe bans the sale of genetically modified foods,…
Newsletter
Cap and Trade, GM’s Bankruptcy and Whole Foods’ Woes
Democrats formally unveil a 932-page bill to restrict greenhouse gas emissions. General Motor Corp.’s proposed bankruptcy filing pits union retirees against GM investors. Profits for…
Newsletter
Europe Investigates Intel, Obama Explodes the Deficit and Minnesota Jumps on the Banned Wagon
European antitrust officials prepare to rule in an investigation of Intel’s microchip marketing practices. The White House estimates that the deficit will explode to $1.8…
Newsletter
The War on Cockroaches, Consumer Credit Shrinks and the Future of Internet Gambling
New York State officials move to limit sale of anti-insect “bug bombs” to consumers. Economists chart a record drop in consumer credit. Rep. Barney Frank…
News Release
Time to Start Paying Organ Donors
Normal 0 false false false MicrosoftInternetExplorer4 Normal 0 false false false MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"";…
Newsletter
Consumer Credit, Social Security and Swine Flu
The House of Representatives votes to limit credit card fees and interest rates. President Obama endorses raising Social Security taxes. Vice President Biden advises Americans…
News Release
Vice President Uses Swine Flu as Anti-Stimulus
The Competitive Enterprise Institute calls on Vice President Biden to repudiate remarks made this morning on “The Today Show” about air travel in the context…
Newsletter
Online Privacy, Credit Cards and Organ Donation
Members of the House Technology & Internet Subcommittee hear testimony on alleged abuses of consumer privacy by internet marketers. President Obama meets with credit card…
Citation
FDA Drug approval delays; new drug called Provenge
Newsletter
Healthy Eating, Big Labor Fights Itself and the War on Mining
A new Food and Drug Administration study sparks debate over the health benefits of eating fish. Factions of the labor union known as UNITE-HERE fight…
Study
The Case for Compensating Live Organ Donors
Full Document Available in PDF Conflicting opinions on the ethics of organ…
Newsletter
Celebrating Earth Day, the FDA Drags Its Feet and Health Scares Debunked
CEI releases a new video titled “Humans Make Earth Day Better.” Promising anti-cancer drug Provenge languishes in the federal approval process despite mounting evidence of…
Comment
CEI Comments on Draft FDA Risk-Benefit Assessment of Fish Consumption
CEI applauds the FDA's even-handed approach.
News Release
Good News, But Prostate Cancer Patients Still Waiting
Sunday’s meeting of the American Association of Cancer Research saw new hope for prostate cancer patients, as researchers announced very favorable results for the drug…
News Release
FDA Investigates Benefits, Dangers of Eating Fish
FDA Investigates Benefits, Dangers of Eating Fish “Consumers Should Not Be Scared Away from Health Benefits of Fish” Washington, D.C., April 21, 2009—The Competitive…
News Release
VIDEO: People Make Earth Day Better
This year, the Competitive Enterprise Institute urges those celebrating Earth Day to remember the challenges presented by living in the natural world, and the inspiring ways that human…
Tulsa Business
Latest Study, Again, Shows Small Car Safety Risk
Tulsa Business
Food Safety Law and Small Producers, Cont’d
Newsletter
Somali Pirates, GM Executives and FDA Regulators
The U.S. military considers attacking Somali pirate bases. Treasury officials instruct General Motors to plan for bankruptcy. The Food and Drug Administration reconsiders its ban…
Blog
Jack Dreyfus, FDA Reform Pioneer
My colleague John Berlau wrote a nice obituary of mutual fund pioneer Jack Dreyfus that was published in Investor’s Business Daily earlier this week.
News Release
Study Argues for Protection of Incremental Drug Advances
Normal 0 false false false MicrosoftInternetExplorer4 Normal 0 false false false MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"";…
Blog
Baptist-Bootlegger Alliance on Tobacco
In today’s Washington Examiner, Tim Carney has an excellent column on how the bill to place tobacco under FDA regulation would reduce competition in…
Tulsa Business
H.R. 875, Food Safety Modernization Act of 2009
Study
Pharmaceutical Evolution
Albert I. Wertheimer and Thomas M. Santella explain the advantages of incremental innovation in drug development. Photo: CC <a href="http://www.flickr.com/photos/joethorn/86495698/">Joe Thorn</a>.
Newsletter
Cancer Treatment, Global Warming Doublespeak and Counting All the Votes in NY
Shares of Dendreon Corp. rise as analysts look forward to new data on its experimental prostate cancer drug, Provenge. Public relations practitioners complain of scientists…
Newsletter
Cancer Drugs, Voting Rights and Cap and Trade Controversy
Author Virginia Postrel details her successful battle against breast cancer. The Justice Department re-considers whether the proposed D.C. voting rights bill is constitutional. States with…
Newsletter
Absurd Product Bans, Global Warming Legislation and Unsafe Organic Farming
Industry observers look to California to take the lead in ending the ban on online gambling. Reps. Henry Waxman and Ed Markey introduce sweeping new…
Blog
Virginia Postrel on Her Own Brush with Cost-Effective Drug Research
One letter writer argues that Herceptin was a poor example because "Multiple cost-effectiveness analyses have shown that, despite its high cost, Herceptin is both effective…
Tulsa Business
Supreme Court Botches Preemption Case
SUPREME COURT BOTCHES PREEMPTION CASE…
Newsletter
AIG’s Tarnished Brand, The White House Vegetable Garden and Global Warming Negotiations
The damage to AIG’s corporate brand may hinder its ability to repay bailout loans from taxpayers. First Lady Michelle Obama announces the creation of a…
Newsletter
Toxic Assets, NIMBYs and Fish Pedicures
Treasury Secretary Timothy Geithner unveils a plan to sell off “toxic assets” as part of the federal bank bailout. The U.S. Chamber of Commerce launches…
Blog
Fishing for Rationality in the Beauty Salon
Thinking of getting one of those cool new “fish pedicures”? Well, you’d better act fast. 14 states have already banned the process. But a member…
Tulsa Business
Needle and the Damage Done
The Supreme Court botches a drug preemption case.
Blog
An Explosion of Litigation
Already burdened by $8 trillion in new federal spending commitments and the likelihood of higher taxes to pay for bailouts,…
Blog
Yes, “Botch” is the right word.
Alex is right. “This IS one of these questions about what to do in the real world, where first-best solutions just aren’t politically possible†(emphasis…
Blog
Did the Supreme Court “Botch” Wyeth v. Levine?
I was initially going to post this as a comment to Greg Conko’s recent post arguing against the Court’s recent decision in Wyeth…
Blog
Supreme Court Botches Preemption Case
Ms. Levine alleged not only that the warning on Phenergan's label wasn't strong enough, but that Phenergan was "not reasonably safe for intravenous administration," and…
Tulsa Business
